Holdings

Acorn Capital Advisors, LLC

As of Sep 30, 2026, Acorn Capital Advisors, LLC reported 19 positions worth US$289M. Largest: CG Oncology, Inc., Puma Biotechnology Inc and Candel Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
CG Oncology, Inc.1.13MUS$80.2Mno changeSep 30, 2026
Puma Biotechnology Inc4.13MUS$41Mno changeSep 30, 2026
Candel Therapeutics, Inc.3.5MUS$36.5Mno changeSep 30, 2026
Trevi Therapeutics, Inc.2.14MUS$30.7Mno changeSep 30, 2026
Cybin, Inc.1.54MUS$18.9Mno changeSep 30, 2026
Jade Biosciences, Inc.987KUS$13.9Mno changeSep 30, 2026
Bicara Therapeutics Inc.668KUS$12.4M+25,000Sep 30, 2026
Verastem, Inc.1.47MUS$11.8Mno changeSep 30, 2026
OnKure Therapeutics, Inc.2.84MUS$7.75Mno changeSep 30, 2026
AN2 Therapeutics, Inc.1.3MUS$6.92MnewSep 30, 2026